Abstract
Atrial fibrillation is the most common sustained cardiac arrhythmia. Dofetilide is an antiarrhythmic drug for the treatment of chronic AF that specifically blocks the rapid component of the delayed rectifier potassium current I Kr . Dofetilide prolongs the action potential duration and QT interval in a concentration-dependent fashion, therefore, the risk of QT prolongation is dose related. It is important to study the electrophysiological effects of dofetilide at different concentrations in human atrial cells. For this, we simulated the effects of dofetilide on human atrial cell and studied its effect on atrial action potential under normal conditions and during cAF. We developed a model of dofetilide effects on I Kr and I KACh . Our results show that dofetilide blocks both currents in a fraction greater as the concentration increases, which results in an action potential duration lengthening. To our knowledge, this is the first work that has developed mathematical models of dofetilide effects on I Kr and I KACh currents to study its effect on human atrial action potential.
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Goralnick E, Bontempo LJ. (2015) Atrial Fibrillation. Emerg. Med. Clin. North Am33(3):597–612.
Aliot E, Haïssaguerre M, Jackman WM. (2008) Catheter Ablation of Atrial Fibrillation. Blackwell Publishing, Oxford.
Zipes DP, Jalife J. (2016) Cardiac Electrophysiology: From Cell to Bedside, Sixth. Elsevier, Philadelphia.
Jurkiewicz NK, Sanguinetti MC. (1993) Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Cir Res 72:75-83.
Lauer MR, Jose S. (2001). Dofetilide: Is the Treatment Worse Than the Disease? J Am Coll Cardiol 37(4):1106–1110.
Saiz J, Ferrero JM, Monserrat M, et al. (2003) Effects of the antiarrhythmic drug dofetilide on myocardial electrical activity: a computer modelling study. Comput Cardiol 291–294.
January CT, Wann LS, Alpert JS, et al. (2014) AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 212.
Jaiswal A, Goldbarg S. (2014) Dofetilide induced torsade de pointes: Mechanism, risk factors and management strategies. Indian Heart J 66(6):640–648.
Zimetbaum P. (2012) Antiarrhythmic drug therapy for atrial fibrillation. Circulation 125(2):381–389.
Courtemanche M, Ramirez RJ, Nattel S. (1998) Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model. Am J Physiol 275(1):H301– H321.
Kneller J, Zou R, Vigmond EJ, et al. (2002) Cholinergic atrial fibrillation in a computer model of a two- dimensional sheet of canine atrial cells with realistic ionic properties. Circ Res90(9):E73–E87.
Courtemanche M, Ramirez RJ, Nattel S. (1999) Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model. Cardiovasc Res 42(2):477–489.
Van Wagoner DR. (2003) Electrophysiological remodeling in human atrial fibrillation. Pacing Clin Electrophysiol 26(7):1572–1575.
Ficker E, Jarolimek W, Kiehn J, et al. (1998) Molecular Determinants of Dofetilide Block of HERG K+ Channels. Circ Res 82:386-395.
Voigt N, Rozmaritsa N, Trausch A, et al. (2010) Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation. Naunyn-Schmied Arch Pharmacol 381: 251-259.
Tande PM, Bjornstad H, Yang T, et al. (1990) Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of the novel blocking drug, UK-68,798: Potent in guinea pig but no effect in rat myocardium. J Cardiovasc Phamacol 16:401-410.
Ohler A, Amos GJ, Wettwer E, et al. (1994) Frequency-dependent effects of E-4031,almokalant, dofetilide and tedisamil on action potencial duration: no evidence for “reverse use dependent” block. Arch Pharmacol 349:602-610.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Nature Singapore Pte Ltd.
About this paper
Cite this paper
Tobón, C., Pérez, S., Ugarte, J.P., Saiz, J. (2017). Dofetilide effect on human atrial action potential under normal and atrial fibrillation conditions. In silico study. In: Torres, I., Bustamante, J., Sierra, D. (eds) VII Latin American Congress on Biomedical Engineering CLAIB 2016, Bucaramanga, Santander, Colombia, October 26th -28th, 2016. IFMBE Proceedings, vol 60. Springer, Singapore. https://doi.org/10.1007/978-981-10-4086-3_10
Download citation
DOI: https://doi.org/10.1007/978-981-10-4086-3_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-4085-6
Online ISBN: 978-981-10-4086-3
eBook Packages: EngineeringEngineering (R0)